Literature DB >> 30136091

Circulatory Mechanotherapeutics: Moving with the Force.

Pablo Huang Zhang1,2, J Yasha Kresh3,4.   

Abstract

PURPOSE OF REVIEW: This review describes the current state of advancements in mechanical circulatory support (MCS) devices with significantly improved hemodynamic performance and decreased adverse events. Novel considerations for future MCS designs that impart spiral flow regimes will be detailed. RECENT
FINDINGS: Significant challenges in MCS device use have included size reduction, premature pump mechanical bearing failure, acquired bleeding disorders, and vascular complications related to high shear forces and jetting. Some of these problems have been improved upon, such as the use of magnetically levitated impellers and hydrodynamic bearings. The relative simplicity of continuous flow pumps has also enabled their miniaturization, portability, and reduced energy consumption. Recent studies by our group demonstrated that spiral forms of flow possess hemodynamically beneficial attributes at the MCS outflow cannula and aorta interface, reducing jet impact, organizing streamlines, and thereby improving endothelial function through wall shear stress modulation. Despite MCS design improvements, they are far from perfect. Induced spiral fluid modulation may help address the known flow-mediated disturbances in vascular mechanobiology.

Entities:  

Keywords:  Mechanical circulatory support (MCS); Mechanobiology; Mechanotransduction; Outflow cannula; Pulsatility; Spiral blood flow

Mesh:

Year:  2018        PMID: 30136091     DOI: 10.1007/s11886-018-1037-0

Source DB:  PubMed          Journal:  Curr Cardiol Rep        ISSN: 1523-3782            Impact factor:   2.931


  24 in total

1.  The future of adult cardiac assist devices: novel systems and mechanical circulatory support strategies.

Authors:  Carlo R Bartoli; Robert D Dowling
Journal:  Cardiol Clin       Date:  2011-11       Impact factor: 2.213

2.  Effect of swirling blood flow on vortex formation at post-stenosis.

Authors:  Hojin Ha; Woorak Choi; Hanwook Park; Sang Joon Lee
Journal:  Proc Inst Mech Eng H       Date:  2015-02       Impact factor: 1.617

Review 3.  Left Ventricular Assist Devices for Lifelong Support.

Authors:  Sean P Pinney; Anelechi C Anyanwu; Anuradha Lala; Jeffrey J Teuteberg; Nir Uriel; Mandeep R Mehra
Journal:  J Am Coll Cardiol       Date:  2017-06-13       Impact factor: 24.094

Review 4.  Left Ventricular Assist Devices: A Rapidly Evolving Alternative to Transplant.

Authors:  Donna Mancini; Paolo C Colombo
Journal:  J Am Coll Cardiol       Date:  2015-06-16       Impact factor: 24.094

5.  Pulsatility and the risk of nonsurgical bleeding in patients supported with the continuous-flow left ventricular assist device HeartMate II.

Authors:  Omar Wever-Pinzon; Craig H Selzman; Stavros G Drakos; Abdulfattah Saidi; Gregory J Stoddard; Edward M Gilbert; Mohamed Labedi; Bruce B Reid; Erin S Davis; Abdallah G Kfoury; Dean Y Li; Josef Stehlik; Feras Bader
Journal:  Circ Heart Fail       Date:  2013-03-11       Impact factor: 8.790

Review 6.  Gastrointestinal bleeding, angiodysplasia, cardiovascular disease, and acquired von Willebrand syndrome.

Authors:  Theodore E Warkentin; Jane C Moore; Sonia S Anand; Eva M Lonn; David G Morgan
Journal:  Transfus Med Rev       Date:  2003-10

Review 7.  Physiological significance of helical flow in the arterial system and its potential clinical applications.

Authors:  Xiao Liu; Anqiang Sun; Yubo Fan; Xiaoyan Deng
Journal:  Ann Biomed Eng       Date:  2014-08-29       Impact factor: 3.934

8.  Computational fluid dynamics in patients with continuous-flow left ventricular assist device support show hemodynamic alterations in the ascending aorta.

Authors:  Christof Karmonik; Sasan Partovi; Matthias Loebe; Bastian Schmack; Alexander Weymann; Alan B Lumsden; Matthias Karck; Arjang Ruhparwar
Journal:  J Thorac Cardiovasc Surg       Date:  2013-12-15       Impact factor: 5.209

9.  Gastrointestinal bleeding rates in recipients of nonpulsatile and pulsatile left ventricular assist devices.

Authors:  Sheri Crow; Ranjit John; Andrew Boyle; Sara Shumway; Kenneth Liao; Monica Colvin-Adams; Carol Toninato; Emil Missov; Marc Pritzker; Cindy Martin; Daniel Garry; William Thomas; Lyle Joyce
Journal:  J Thorac Cardiovasc Surg       Date:  2008-10-10       Impact factor: 5.209

10.  Clinical differences between continuous flow ventricular assist devices: a comparison between HeartMate II and HeartWare HVAD.

Authors:  Spencer D Lalonde; Ana C Alba; Alanna Rigobon; Heather J Ross; Diego H Delgado; Filio Billia; Michael McDonald; Robert J Cusimano; Terrence M Yau; Vivek Rao
Journal:  J Card Surg       Date:  2013-07-11       Impact factor: 1.620

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.